Drug Recalls Archives - Page 14 of 45

Obtryx Pelvic Mesh Manufacturer Loses $18.5 Million Award Appeal

December 24, 2016 By US Recall News Leave a Comment

The manufacturer of the pelvic mesh product, Obtryx, has failed in its effort to appeal awards totaling $18.5 million to four different women in a product liability trial. Boston Scientific was ordered to pay each plaintiff an amount of up to $4.25 million in compensation for their injuries after receiving the Obtryx device. How Did This Happen? … [Read more...]

Risperdal Infographic

December 13, 2016 By Melody Klein Leave a Comment

Risperdal is a drug manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. It was developed and originally approved in 1993 to be used as an antipsychotic medication. However, soon after receiving its original FDA-approval, Janssen began to market Risperdal to those who were not originally intended to take the drug; … [Read more...]

Heartburn Medication Linked to Increased Risk of First Time Stroke

December 12, 2016 By US Recall News Leave a Comment

Heartburn and acid reflux are admittedly uncomfortable conditions. However, solving these problems has created an even worse problem for patients. Popular yet dangerous Proton pump inhibitors are the most common medications prescribed for the treatment of heartburn and acid reflux. They are widely available over the counter and have proven … [Read more...]

43 States and the District of Columbia Settle Abilify Lawsuit

December 12, 2016 By US Recall News Leave a Comment

On Thursday, Bristol-Myers Squibb agreed to settle a lawsuit including charges from 43 states and the District of Columbia for $19.5 million. The charges brought in the lawsuit concern the marketing of Abilify, an atypical antipsychotic drug produced to treat multiple forms of bipolar, schizophrenia, and Tourette’s disorder. The Problem With … [Read more...]

J&J Wants to Move Talc Cases after $195 Million in Verdicts

November 8, 2016 By US Recall News Leave a Comment

So far this year, in a single court in St. Louis, Johnson & Johnson (J&J) has been ordered to pay nearly $200 million to women who developed ovarian cancer after using its talcum powder products for feminine hygiene, or to the families of women who died. That was just three cases, and there are about 2,500 more pending. Now, J&J … [Read more...]